These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 24695358)

  • 21. Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia.
    Todd KE; Ahanchi SS; Maurer CA; Kim JH; Chipman CR; Panneton JM
    J Vasc Surg; 2013 Oct; 58(4):941-8. PubMed ID: 23755978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
    Ascher E; Marks NA; Hingorani AP; Schutzer RW; Mutyala M
    J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease.
    Malas MB; Enwerem N; Qazi U; Brown B; Schneider EB; Reifsnyder T; Freischlag JA; Perler BA
    J Vasc Surg; 2014 Jan; 59(1):129-35. PubMed ID: 23891488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome of femoropopliteal stenting. Results of a prospective study.
    Schönefeld E; Torsello G; Osada N; Herten M; Bisdas T; Donas KP
    J Cardiovasc Surg (Torino); 2013 Oct; 54(5):617-23. PubMed ID: 24002391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective stenting in subintimal angioplasty: analysis of primary stent outcomes.
    Schmieder GC; Richardson AI; Scott EC; Stokes GK; Meier GH; Panneton JM
    J Vasc Surg; 2008 Nov; 48(5):1175-80; discussion 1180-1. PubMed ID: 18778911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three year results of endovascular therapy with a new generation nitinol stent for femoro-popliteal artery lesions - a single-center outcome analysis of a subcohort of MISAGO 2 study.
    Kralj I; Boos I; Müller-Bühl U
    Vasa; 2013 Sep; 42(5):340-9. PubMed ID: 23989069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endovascular interventions for TASC II D femoropopliteal lesions.
    Baril DT; Chaer RA; Rhee RY; Makaroun MS; Marone LK
    J Vasc Surg; 2010 Jun; 51(6):1406-12. PubMed ID: 20385464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of chronic kidney disease on outcomes of superficial femoral artery endoluminal interventions.
    Bakken AM; Protack CD; Saad WE; Hart JP; Rhodes JM; Waldman DL; Davies MG
    Ann Vasc Surg; 2009; 23(5):560-8. PubMed ID: 19128934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High dose-rate brachytherapy for the treatment of lower extremity in-stent restenosis.
    Ho KJ; Devlin PM; Madenci AL; Semel ME; Gravereaux EC; Nguyen LL; Belkin M; Menard MT
    J Vasc Surg; 2017 Mar; 65(3):734-743. PubMed ID: 27986482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of sex on angioplasty and primary stenting for femoropopliteal occlusive disease: results of the DURABILITY II trial.
    Tadros RO; Faries PL; Rocha-Singh KJ; Kim Sy; Malik RK; Ellozy SH; Marin ML; Vouyouka AG
    Ann Vasc Surg; 2014 Jan; 28(1):1-9. PubMed ID: 24189009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute and long-term outcome of Silverhawk assisted atherectomy for femoro-popliteal lesions according the TASC II classification: a single-center experience.
    Sixt S; Rastan A; Beschorner U; Noory E; Schwarzwälder U; Bürgelin K; Schwarz T; Müller C; Hauk M; Brantner R; Möhrle C; Linnemann B; Macharzina R; Neumann FJ; Zeller T
    Vasa; 2010 Aug; 39(3):229-36. PubMed ID: 20737381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia.
    Biagioni RB; Brandão GD; Biagioni LC; Nasser F; Burihan MC; Ingrund JC
    J Vasc Surg; 2019 May; 69(5):1510-1518. PubMed ID: 30611581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endovascular recanalization of native chronic total occlusions in patients with failed lower-extremity bypass grafts.
    Wrigley CW; Vance A; Niesen T; Grilli C; Velez JD; Agriantonis DJ; Kimbiris G; Garcia MJ; Leung DA
    J Vasc Interv Radiol; 2014 Sep; 25(9):1353-9. PubMed ID: 25060042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial.
    Laird JR; Jain A; Zeller T; Feldman R; Scheinert D; Popma JJ; Armstrong EJ; Jaff MR;
    J Endovasc Ther; 2014 Apr; 21(2):202-12. PubMed ID: 24754279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
    Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
    J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score.
    Ihnat DM; Duong ST; Taylor ZC; Leon LR; Mills JL; Goshima KR; Echeverri JA; Arslan B
    J Vasc Surg; 2008 May; 47(5):967-74. PubMed ID: 18372147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents.
    Chan YC; Cheng SW; Ting AC; Cheung GC
    J Vasc Surg; 2014 Feb; 59(2):384-91. PubMed ID: 24461862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of endovascular treatment for trans-Atlantic inter-society consensus II type B Iliac lesions in patients aged <50 years.
    Radak D; Babic S; Sagic D; Antonic Z; Kovacevic V; Stevanovic P; Tanaskovic S; Sotirovic V; Otasevic P
    Ann Vasc Surg; 2012 Nov; 26(8):1057-63. PubMed ID: 22410143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single center experience of Zilver PTX for femoro-popliteal lesions.
    Kang WY; Campia U; Didier RJ; Kiramijyan S; Koifman E; Negi SI; Lipinski MJ; Baker NC; Escarcega RO; Torguson R; Waksman R; Bernardo NL
    Cardiovasc Revasc Med; 2016 Sep; 17(6):399-403. PubMed ID: 27496591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of endovascular therapy for femoropopliteal disease with the Supera stent.
    Montero-Baker M; Ziomek GJ; Leon L; Gonzales A; Dieter RS; Gadd CL; Pacanowski JP
    J Vasc Surg; 2016 Oct; 64(4):1002-8. PubMed ID: 27444365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.